https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-data-for-pancreasure-vid-screening-av-patienter-med-arftlig-eller-familjar-risk-for-bukspottkortelcancer 2026-10-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-publ-2 2026-09-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-genomfor-en-foretradesemission-av-units-om-cirka-63-msek 2026-09-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lamnar-in-formell-ansokan-om-ersattningsratt-fran-medicare-for-pancreasure 2026-09-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-enkatresultat-som-visar-starkt-stod-bland-patienter-for-blodbaserade-tester-for-tidigare-upptackt-av-bukspottkortelcancer 2026-08-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-april-juni-2026 2026-08-06 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-presentation-av-q2-rapport-2026 2026-08-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-nya-prestandadata-for-pancreasure-infor-kommande-ansokan-om-medicare-ersattning 2026-06-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-slutgiltiga-resultat-fran-affirm-studien-i-journal-of-clinical-oncology-som-bekraftar-stark-diagnostisk-prestanda-for-pancreasure 2026-06-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-den-13-maj-2026-i-immunovia-ab-publ 2026-05-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2026-1 2026-05-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2026 2026-05-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-initierar-registerstudien-assure-for-att-utvardera-nyttan-av-pancreasure-vid-overvakning-av-individer-med-hog-risk-for-bukspottkortelcancer 2026-05-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-presentation-av-q1-rapport-och-strategiska-mal-for-2026 2026-05-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-publ-1 2026-04-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-2025 2026-04-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-bokslutskommunike-2025 2026-02-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-kvartalsrapport-for-q4-2025 2026-02-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-pa-aktiespararna-life-science 2026-01-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelsen-i-immunovia-drar-tillbaka-forslag-om-sammanlaggning-av-aktier-och-staller-in-extra-bolagsstamma 2026-01-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-erhaller-regulatoriskt-godkannande-for-pancreasure-i-kalifornien-och-inleder-kommersiell-lansering 2026-01-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-faststaller-valberedning-for-2026 2026-01-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-analytiska-valideringsstudie-av-pancreasure-publicerad-i-diagnostics 2025-12-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-publ-1 2025-12-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelsen-for-immunovia-foreslar-en-sammanlaggning-av-aktier 2025-12-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=andring-av-antalet-aktier-och-roster-i-immunovia-ab-publ-1 2025-11-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-far-faststalld-medicare-ersattningsniva-for-pancreasure-testet 2025-11-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-juli-september-2025 2025-11-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=verifi-studien-publicerad-i-peer-reviewade-tidskriften-current-oncology 2025-11-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-q3-presentation 2025-11-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-genomfor-en-riktad-nyemission-av-aktier-till-garanter-i-samband-med-den-genomforda-foretradesemissionen 2025-10-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-pancreasure-studie-publicerad-i-den-ledande-tidskriften-gastroenterology 2025-10-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kliniska-valideringsdata-for-pancreasure-presenteras-vid-american-gastroenterology-annual-scientific-meeting 2025-10-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-utfallet-i-foretradesemissionen 2025-10-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=sista-dag-for-handel-med-teckningsratter-i-immunovias-foretradesemission 2025-10-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-laboratorium-tilldelas-cap-ackreditering 2025-10-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-uppmarksammar-pancreasure-presentation-vid-konferens-om-arftliga-gastrointestinala-cancerformer 2025-10-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-informationsdokument-avseende-foretradesemission 2025-10-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-immunovia-ab-publ 2025-09-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-slutliga-villkor-i-foretradesemission 2025-09-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=pancreasure-visar-88-kanslighet-och-98-specificitet-i-preliminara-resultat-i-en-tredje-valideringsstudie 2025-09-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-sakrar-kontroll-over-pancreasure-testets-leverantorskedja-och-minskar-kostnader-genom-licensavtal 2025-09-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inova-schar-cancer-infor-immunovias-pancreasure-test-i-sitt-screeningprogram-for-hogriskpatienter 2025-09-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=centers-for-medicare-and-medicaid-services-utfardar-preliminart-faststallande-av-ersattning-for-immunovias-pancreasure-test 2025-09-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ingar-toppgarantiataganden-for-den-kommande-foretradesemissionen 2025-09-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=pancreasure-test-for-tidig-upptackt-av-bukspottkortelcancer-tillgangligt-for-hogriskpatienter-forsta-testerna-ar-redan-bestallda 2025-09-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-juni-2025 2025-08-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-publ 2025-08-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-genomfor-en-foretradesemission-om-cirka-100-msek-och-sakrar-brygglan 2025-08-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-q2-presentation 2025-08-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lanserar-pancreasure-i-usa-den-2-september-och-presenterar-kommersiell-strategi 2025-08-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-analytiska-valideringsstudie-far-utmarkelse-for-sin-vetenskapliga-excellens-av-adlm 2025-07-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-natalie-carfora-till-vp-market-access-and-reimbursement 2025-07-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-test-pancreasure-erhaller-ama-cmt-code-for-fakturering-och-ersattning 2025-07-01 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-modellutvecklingsstudie-publicerad-i-tidsskriften-cancers 2025-06-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=leiden-university-inleder-studie-av-immunovias-pancreasure-test-i-grupp-med-ovanligt-hog-risk-for-bukspottkortelcancer 2025-06-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lyfts-fram-vid-amerikansk-vetenskaplig-workshop-om-tidig-cancerdiagnostik-den-21-maj 2025-05-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-den-14-maj-2025-i-immunovia-ab-publ 2025-05-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q1 2025-05-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2025 2025-05-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=clariti-studien-uppmarksammad-pa-best-of-digestive-disease-week 2025-05-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=pancreasure-immunovias-nya-test-for-tidig-upptackt-av-bukspottkortelcancer 2025-05-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=andring-av-antalet-aktier-och-roster-i-immunovia-ab-publ 2025-04-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-meddelar-utfall-for-nyttjandet-av-teckningsoptioner-serie-to-3 2025-04-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-medverkar-pa-aktiespararnas-life-science-kvall-den-23-april 2025-04-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-publ 2025-04-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=sista-dag-for-handel-med-teckningsoptioner-serie-to-3-i-immunovia 2025-04-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-vd-och-styrelseledamoter-meddelar-avsikt-att-fullt-ut-nyttja-sina-teckningsoptioner-av-serie-to-3 2025-04-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-2024-ad97c395 2025-04-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nyttjandeperioden-for-teckningsoptioner-serie-to-3-inleds-idag-f066f45b 2025-04-01 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-faststalld-teckningskurs-for-teckningsoptioner-serie-to-3-a1d7b86a 2025-03-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillhandahaller-ytterligare-positiva-data-fran-verifi-studien-av-nasta-generations-test-for-bukspottkortelcancer-d770f44a 2025-03-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-webbsandning-for-att-dela-med-sig-av-mer-data-fran-den-framgangsrika-kliniska-valideringsstudien-verifi-f485c70a 2025-03-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-ytterligare-en-framgangsrik-klinisk-validering-av-nasta-generations-test-for-bukspottkortelcancer-dddbab93 2025-03-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=resultaten-fran-immunovias-clariti-studie-utvald-for-prestigefylld-presentation-vid-varldens-storsta-gastroenterologikonferens-90fbc7c5 2025-03-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-bokslutskommunike-2024-286af22b 2025-02-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-rekrytering-efter-en-ny-cfo-infor-kommersialisering-i-usa-d5cb92fb 2025-02-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q4-1f33d6a7 2025-02-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=andring-av-antalet-aktier-och-roster-i-immunovia-ab-publ-a89204e7 2025-01-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-meddelar-utfall-for-nyttjandet-av-teckningsoptioner-serie-to-2-a3d477b5 2025-01-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-publ-presenterar-valberedningen-f7150108 2025-01-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nyttjandeperioden-for-teckningsoptioner-av-serie-to-2-inleds-idag-bf598d20 2025-01-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-faststalld-teckningskurs-for-teckningsoptioner-serie-to-2-samt-villkorat-sakerstallt-nyttjande-av-65-av-teckningsoptionsprogrammet-750c5cc8 2024-12-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-discovery-studie-publicerad-i-framstaende-tidskrift-for-proteinforskning-675cc7c8 2024-12-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=summering-av-2024-brev-fran-jeff-borcherding-ceo-immunovia-40ca6f8e 2024-12-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-vd-och-styrelseledamoter-meddelar-avsikt-att-fullt-ut-nyttja-sina-teckningsoptioner-av-serie-to2-32791114 2024-12-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-en-webbsandning-med-mojlighet-att-lara-mer-om-den-positiva-kliniska-valideringen-av-nasta-generations-test-for-bukspottkortelcancer-76073ffc 2024-12-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-finansiell-kalendern-for-finansaret-2025-2026-9f6ba863 2024-12-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillkannager-positivt-resultat-och-hog-precision-i-den-kliniska-valideringen-av-nasta-generations-test-for-bukspottkortelcancer-4c24d5e7 2024-12-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-pa-redeye-technology-and-life-science-day-ce4c72fe 2024-11-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-september-2024-0b93502b 2024-11-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-data-fran-modellutvecklingsstudien-vid-arsmotet-for-the-collaborative-group-of-the-americas-inherited-gastrointestinal-cancers-7f3370be 2024-11-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q3-30e171f3 2024-11-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-data-fran-modellutvecklingsstudien-vid-precede-pancreatic-cancer-research-consortium-mote-9c36813c 2024-11-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-framgangsrikt-forvarvat-samtliga-blodprover-som-kravs-for-att-kliniskt-validera-nasta-generations-test-for-bukspottkortelcancer-591e0d96 2024-10-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-slutfor-analytisk-validering-av-sitt-nasta-generations-test-for-bukspottkortelcancer-2d515666 2024-10-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=andring-av-antalet-aktier-och-roster-i-immunovia-ab-publ-30691261 2024-09-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-data-fran-modellutvecklingsstudie-vid-2024-aacr-advances-in-pancreatic-cancer-medical-conference-353d26c4 2024-09-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-genomfor-en-riktad-emission-av-units-till-garanter-i-samband-med-den-genomforda-foretradesemissionen-650d8941 2024-09-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-slutligt-utfall-i-foretradesemission-87f12597 2024-09-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-preliminart-utfall-i-foretradesemission-82080ca5 2024-09-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-prospekt-i-samband-med-foretradesemission-99c6300c 2024-08-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-slutliga-villkor-i-foretradesemission-bd1d659c 2024-08-06 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-juni-2024-4c5aa468 2024-08-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-nasta-generations-test-kommer-att-inkluderas-i-en-stor-studie-av-bukspottkortelcystor-finansierad-av-u-s-national-institutes-of-health-bc5aa7e1 2024-08-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lamnar-in-patentansokan-i-usa-for-att-skydda-nasta-generations-test-4bf66ae3 2024-08-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-slutfor-utvecklingen-av-sitt-test-for-upptackt-av-bukspottkortelcancer-dar-testnoggrannheten-har-okat-vasentligt-f0ac0106 2024-08-01 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q2-ee80365b 2024-07-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-data-fran-discovery-studien-vid-den-medicinska-konferensen-pancreasfest-2024-1dfca787 2024-07-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-nya-labb-bemannat-och-i-drift-efter-en-snabb-implementering-712c973a 2024-07-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-den-19-juni-2024-i-immunovia-ab-publ-4b47bacb 2024-06-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-publ-f16d5a46 2024-05-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-genomfor-en-foretradesemission-av-units-om-cirka-70-msek-samt-upptar-brygglan-6a0c4ede 2024-05-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-effektiviserar-labbverksamheten-genom-flytt-till-research-triangle-park-north-carolina-4322fb66 2024-04-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-dr-lisa-ford-till-klinisk-laboratoriechef-8dd934c3 2024-04-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-2023-587abd76 2024-04-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2024-197c65ff 2024-04-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q1-3edd2542 2024-04-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-uppdaterar-sin-finansiella-kalender-b30941b8 2024-04-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-positiva-resultat-fran-modellutvecklingsstudien-for-sitt-nasta-generationens-test-for-upptackt-av-bukspottkortelcancer-1f008d0d 2024-04-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-framgangsrikt-utvecklat-analyser-for-att-mata-proteiner-for-nasta-generations-test-for-bukspottkortelcancer-pa-vag-mot-modellutvecklingsstudie-79e1d88e 2024-04-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-uppdaterar-sin-finansiella-kalender-9ac54405 2024-03-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-bokslutskommunike-2023-d8c60e13 2024-02-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q4-b772f4c2 2024-02-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-norma-alonzo-palma-till-ny-vice-president-of-clinical-and-medical-affairs-31a2e0e6 2024-01-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-finansiell-kalendern-for-finansaret-2024-48cac696 2024-01-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-immunovia-ab-904eb9d4 2023-11-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-september-2023-dd796129 2023-11-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-att-man-framgangsrikt-slutfort-discoveryfasen-av-nasta-generations-test-d1f23886 2023-11-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q3-a9b2b2fd 2023-11-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-publ-905cf28b 2023-10-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-i-immunovia-ab-publ-0dc68296 2023-10-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-juni-2023-5578aa38 2023-08-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q2-f995fd6c 2023-08-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-uppdaterar-sin-finansiella-kalender-be129974 2023-07-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-omstrukturerar-vasentligt-for-att-fokusera-resurser-pa-nasta-generations-blodtest-for-upptackt-av-pankreascancer-6fc7bf5d 2023-07-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=verkstallande-direktor-jeff-borcherding-koper-immunovia-aktier-a7024b6d 2023-06-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=forandring-av-antal-aktier-och-roster-i-immunovia-ab-publ-8cff053d 2023-05-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-immunovia-ab-f615b74d 2023-05-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2023-aad550fe 2023-05-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=andringar-av-valberedningens-forslag-till-arsstamman-2023-i-immunovia-ab-publ-f7fe1b11 2023-05-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q1-64cab985 2023-05-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelseledamoten-philipp-von-hugo-lamnar-immunovias-styrelse-pa-egen-begaran-85a731db 2023-05-06 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-utser-ny-vd-f7e1be11 2023-04-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-diskuterar-anvandning-av-immray-r-pancan-d-med-viktiga-opinionsbildare-den-3-maj-2023-37d6f240 2023-04-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-fff5d0db 2023-04-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-2022-ba0819a1 2023-04-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-deltar-i-national-pancreas-foundations-webinar-om-biomarkorer-och-vatskebiopsi-for-tidig-upptackt-av-bukspottkortelcancer-f339e30f 2023-04-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-utfall-i-foretradesemissionen-c1ffe2a2 2023-04-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-uppdaterad-finansiell-kalendern-for-finansaret-2023-42ebeec8 2023-03-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-announces-updated-financial-calendar-for-financial-year-2023-a825a2ca 2023-03-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-prospekt-i-samband-med-foretradesemissionen-154f139c 2023-03-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-immunovia-ab-b95ed35d 2023-03-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-karl-stone-till-ny-coo-for-att-utveckla-fou-verksamheten-6f5c9b62 2023-03-01 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-bokslutskommunike-2022-3b2f2f28 2023-02-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q4-4a0561ad 2023-02-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-0af7bf55 2023-02-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-beslutar-om-en-foretradesemission-om-cirka-202-2-miljoner-sek-och-senarelagger-offentliggorandet-av-kvartalsrapport-for-det-forsta-kvartalet-och-arsstamman-7407264c 2023-02-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=samradsprocessen-med-svenska-fackforbund-avslutad-ba01d5d3 2023-02-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-uppdaterad-finansiell-kalendern-for-finansaret-2023-92f2e6dc 2023-01-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-anpassar-den-svenska-verksamheten-for-att-stodja-strategiskt-fokus-och-kommersialisering-av-immray-r-pancan-d-testet-i-usa-7d1d77f1 2023-01-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-lara-e-sucheston-campbell-till-head-of-clinical-and-medical-affairs-for-att-paskynda-den-kommersiella-strategin-av-immray-r-pancan-d-testet-pa-den-amerikanska-marknaden-201c4534 2023-01-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-starker-verksamheten-i-usa-for-den-fortsatta-kommersialiseringen-av-det-unika-immray-r-pancan-d-testet-b9fb9eaa 2022-12-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=centers-for-medicare-and-medicaid-services-slutfor-ersattningsbeslut-och-faststaller-en-ersattning-pa-usd-897-for-immunovias-immray-pancan-d-test-dc108056 2022-11-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=verkstallande-direktor-philipp-mathieu-koper-immunovia-teckningsoptioner-cb666ce4 2022-11-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-den-finansiella-kalendern-for-finansaret-2023-7afd1bc9 2022-11-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-september-2022-ea361613 2022-11-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q3-2c11909d 2022-11-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-infor-arsstamma-2023-i-immunovia-ab-publ-b466c556 2022-10-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-forandringar-i-ledningsgruppen-for-att-accelerera-genomforandet-av-strategiska-prioriteringar-bad3690d 2022-10-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lanserar-ett-strategiskt-partnerskap-med-proteomedix-for-att-oka-kraften-i-forskning-och-utveckling-samt-oka-det-kommersiella-fokuset-00c3d953 2022-10-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-positiv-aterkoppling-gallande-erfarenhetsprogram-med-immray-r-pancan-d-da5e0a26 2022-10-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=centers-for-medicare-and-medicaid-services-utfardar-prelimininart-faststallande-av-ersattning-for-immunovias-immray-pancan-d-test-56d39e69 2022-09-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-juni-2022-9a74a48d 2022-08-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-kommer-att-presentera-pa-gilmartin-groups-emerging-growth-company-showcase-6288fc65 2022-08-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q2-b16d084b 2022-08-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inc-erhaller-licencsrattigheter-fran-halsodepartementet-i-kalifornien-for-immray-r-pancan-d-test-dee92d3c 2022-08-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=cpt-pla-kod-for-testet-immray-r-pancan-d-godkant-51fe985a 2022-07-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=pandia-1-studien-for-tidig-upptackt-av-bukspottkortelcancer-vid-typ-2-diabetes-gar-vidare-till-nasta-fas-49b81ff3 2022-06-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-resultat-for-panfam-1-1c7d4b31 2022-06-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=resultat-for-panfam-1-delvis-ofullstandigt-a7e86414 2022-06-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=philipp-mathieu-utnamnd-till-vd-for-immunovia-ab-1787cdcb 2022-06-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=okad-marknadstillgang-nar-immunovia-inc-erhaller-licensrattigheter-for-kliniska-laboratorier-fran-pennsylvanias-och-marylands-halsodepartement-3c80c35d 2022-05-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inc-erhaller-licensrattigheter-for-kliniska-laboratorier-fran-rhode-islands-halsodepartement-vilket-gor-testet-immray-r-pancan-d-tillgangligt-i-46-amerikanska-delstater-b1a0f74d 2022-05-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-starker-sitt-amerikanska-team-genom-utnamningen-av-natalie-carfora-till-head-of-market-access-us-f41b454e 2022-05-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2022-2b6a325d 2022-04-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q1-03ef4985 2022-04-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-ansokan-om-cpt-r-pla-kod-for-testet-immray-pancan-d-pa-agendan-hos-american-medical-association-6c5631a1 2022-04-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-immunovia-ab-dddf716f 2022-04-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-jeff-borcherding-tidigare-marknadschef-pa-myriad-genetics-till-att-leda-immunovias-usa-verksamhet-358eb9ea 2022-03-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-2021-95a017ea 2022-03-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inc-s-laboratorium-erhaller-ackreditering-fran-college-of-american-pathologists-ett-betydande-steg-i-den-rikstackande-utrullningen-av-immray-r-pancan-d-i-usa-a86e5fd8 2022-03-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-starker-ip-portfoljen-ytterligare-for-immray-r-pancan-d-signaturen-7871ebdc 2022-03-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-publ-31e3ca08 2022-03-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuds-in-till-cowens-42-a-arliga-halso-och-sjukvardskonferens-46228b36 2022-02-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-bokslutskommunike-2021-773cac08 2022-02-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immray-r-pancan-d-referensgranskad-blinda-valideringsstudien-publicerad-i-clinical-and-translational-gastroenterology-3f1652b9 2022-02-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-presentation-av-q4-99574dc2 2022-02-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-flyttar-fram-arsstamman-beroende-pa-den-tillfalliga-stammolagen-3e08aefc 2022-02-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-philipp-mathieu-som-tillforordnad-vd-67ca1747 2022-01-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-ny-senior-director-investor-relations-and-corporate-communications-ddaca33a 2021-11-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-hogtidliggjorde-world-pancreatic-cancer-day-genom-att-fira-invigningen-av-det-amerikanska-dotterbolaget-immunovia-inc-a09c9ff3 2021-11-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-rapport-for-tredje-kvartalet-2021-a3a6be9e 2021-11-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-pa-jefferies-london-healthcare-conference-03c16c6d 2021-11-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inc-s-medical-director-dr-thomas-king-inbjuden-som-huvudtalare-av-us-national-cancer-institute-8ac5e94c 2021-10-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-september-2021-f5f705fd 2021-10-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tilldelas-utmarkelsen-presidential-poster-award-vid-american-college-of-gastroenterologys-arliga-vetenskapskonferens-186e9bfc 2021-10-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-infor-arsstamma-2022-i-immunovia-ab-publ-7828f0da 2021-10-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-ny-chief-financial-officer-17590426 2021-10-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=usa-baserade-pancreatic-cancer-action-network-informerar-sina-medlemmar-om-immunovias-blodtest-immray-r-pancan-d-e2f477ef 2021-09-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ingar-licensavtal-med-jw-bioscience-avseende-biomarkorer-for-bukspottkortelcancer-7a6efa77 2021-09-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelseledamot-i-immunovia-koper-aktier-i-bolaget-2bd8871e 2021-09-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-rapport-for-andra-kvartalet-2021-294d592c 2021-08-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-juni-2021-43a556b3 2021-08-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-listpris-for-immray-r-pancan-d-i-usa-och-forbattrad-prestanda-i-den-familjara-arftliga-riskgruppen-c47f8069 2021-08-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inc-far-godkant-att-anvanda-testet-immray-r-pancan-d-for-tidig-upptackt-av-bukspottkortelcancer-i-usa-097eba05 2021-08-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inc-erhaller-lagstadgat-registreringsbevis-licensieringen-av-laboratoriet-pagar-fortfarande-7d9b1732 2021-06-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=verkstallande-direktor-patrik-dahlen-koper-aktier-i-immunovia-cbd774e6 2021-05-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-key-opinion-leader-event-om-den-kliniska-anvandningen-av-immray-r-pancan-d-2913af20 2021-05-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelseledamot-i-immunovia-koper-aktier-i-bolaget-1f025af3 2021-05-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-immunovia-ab-54305b24 2021-05-06 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelseledamoter-i-immunovia-koper-aktier-i-bolaget-73a4cc5d 2021-05-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-delarsrapport-januari-mars-2021-be7546b2 2021-04-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-process-for-att-uppna-kostnadsersattning-for-immray-r-pancan-d-f5cf19cb 2021-04-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-uppdatering-av-marknadens-storlek-i-usa-for-immray-r-pancan-d-i-den-familjara-arftliga-riskgruppen-3439d74f 2021-04-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-mars-2021-0de29cbf 2021-04-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immray-r-pancan-d-uppmarksammades-i-mote-arrangerat-av-pancreatic-cancer-action-network-3d635c24 2021-04-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-d8a61cc5 2021-03-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-rapporterar-positiva-resultat-for-immray-r-pancan-d-blodbaserade-test-i-blindad-klinisk-valideringsstudie-utford-i-usa-0a2e12d4 2021-03-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-rapporterar-forbattrad-testprestanda-for-immray-r-pancan-d-for-upptackt-av-bukspottkortelcancer-i-tidigt-stadium-hos-hogriskpatienter-med-symptom-c1328a92 2021-03-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-rakenskapsaret-2020-121e332e 2021-03-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-datan-fran-optimeringsstudien-och-commercial-test-model-study-abcb463f 2021-02-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bokslutskommunike-2020-7d986578 2021-02-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-panfam-1-prospektiva-studie-samlar-over-3000-prover-fran-patienter-med-risk-for-familjar-arftlig-bukspottkortelcancer-for-analys-under-andra-halvaret-2021-21a04280 2021-02-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-bokslutskommunike-2020-den-17-februari-2021-24e77eb6 2021-02-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-pa-vag-mot-forsaljningsstart-av-immray-r-pancan-d-under-forsta-kvartalet-2021-d44f6084 2021-02-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=verkstallande-direktor-patrik-dahlen-koper-immunovia-teckningsoptioner-b572b834 2021-01-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=proteomdata-baserade-pa-immunovias-immray-r-plattform-mojliggor-differentialdiagnos-av-svarbedomda-autoimmuna-sjukdomar-62d9c518 2021-01-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-lank-till-webbinarium-nr-3-om-immray-r-pancan-d-verifieringsstudie-och-klinisk-anvandning-1394a6af 2020-12-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-arrangerar-ett-tredje-webbinarium-i-serien-om-immray-r-pancan-d-verifieringsstudie-och-klinisk-anvandning-a528d57b 2020-12-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillkannager-forandringar-inom-investor-relations-f1b980c0 2020-12-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelseledamoter-i-immunovia-koper-aktier-i-bolaget-3553e58a 2020-12-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-telefonkonferens-med-anledning-av-artikel-i-dagens-industri-den-1-december-5f01c32d 2020-12-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=verkstallande-direktor-patrik-dahlen-koper-immunovia-aktier-d397e116 2020-11-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-rapporterar-delarsrapport-for-tredje-kvartalet-januari-september-2020-1ecc68f8 2020-11-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=korrigerad-version-valberedning-utsedd-infor-arsstamma-2021-i-immunovia-ab-publ-48272f75 2020-11-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-infor-arsstamma-2021-i-immunovia-ab-publ-eb2421c4 2020-11-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-september-2020-den-12-november-2020-4b3de9c5 2020-11-06 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-kompletterande-information-om-immray-r-pancan-d-verifieringsstudien-5176fb34 2020-11-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=forandring-av-antal-aktier-och-roster-i-immunovia-ab-publ-3b788c00 2020-10-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-haller-ett-webinar-for-att-presentera-ny-vd-patrik-dahlen-ddf6df90 2020-10-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillhandahaller-kompletterande-information-om-immray-r-pancan-d-verifierings-och-valideringsstudier-f41a921b 2020-10-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-att-analysen-av-verifieringsstudien-for-immray-r-pancan-d-har-slutforts-cc0d31fe 2020-10-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-positiva-resultat-fran-verifieringsstudien-for-immray-r-pancan-d-2f12162b 2020-09-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=stammokommunike-fran-immunovias-extra-bolagsstamma-0d76e3ab 2020-09-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-forandringar-i-ledningsgruppen-b9552fbe 2020-09-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-e02009ce 2020-08-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=registreringsdetaljer-till-immunovias-andra-online-presentation-om-immray-r-pancan-d-commercial-test-model-study-and-uppdatering-av-lanseringsaktiviteter-f0303d1d 2020-08-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-annonserar-vd-succession-utser-patrik-dahlen-till-ny-vd-efd3e8a7 2020-08-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-rapporterar-delarsrapport-for-andra-kvartalet-januari-juni-2020-9be18139 2020-08-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-haller-en-andra-online-presentation-om-immray-r-pancan-d-commercial-test-model-study-and-uppdatering-av-lanseringsaktiviteter-13f71b3e 2020-08-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-juni-2020-den-20-augusti-2020-d6794e35 2020-08-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=forandring-av-antal-aktier-och-roster-i-immunovia-ab-publ-7cf6e641 2020-06-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-satter-mal-for-langsiktig-marknadspenetration-pa-30-procent-for-immray-r-pancan-d-d94df8d0 2020-06-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-pa-ett-satellitsymposium-vid-european-pancreatic-club-epc-international-association-of-pancreatology-iap-arsmote-den-2-juli-2020-2981d3ad 2020-06-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=registreringsinformation-for-immunovias-virtuella-investerardag-pa-tisdag-den-30-juni-2020-d7e51a96 2020-06-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utokar-sitt-lungcancerprogram-baserat-pa-l-ovande-resultat-fran-den-aktuella-forskningsstudien-f30129eb 2020-06-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-haller-en-virtuell-investerardag-pa-tisdag-30-juni-2020-abcefaf0 2020-06-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=korrigerad-version-immunovia-tillfordes-cirka-400-msek-for-att-ytterligare-paskynda-marknadsintroduktionen-av-det-forsta-testet-for-tidig-upptackt-av-bukspottkortelcancer-immray-r-pancan-d-a336506f 2020-06-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillfordes-cirka-400-msek-for-att-ytterligare-paskynda-marknadsintroduktionen-av-det-forsta-testet-for-tidig-upptackt-av-bukspottkortelcancer-immray-r-pancan-d-89d4e851 2020-06-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-genomfort-en-riktad-nyemission-av-aktier-och-tillfors-harigenom-cirka-400-msek-5046060c 2020-06-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-avsikt-att-genomfora-en-riktad-nyemission-av-aktier-genom-ett-accelererat-bookbuilding-forfarande-4f7f9920 2020-06-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lamnar-en-fjarde-uppdatering-under-covid-19-pandemin-dcbb7ee5 2020-05-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-uppdatering-nr-4-om-foretagets-svar-pa-covid-19-3a63812a 2020-05-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lamnar-en-tredje-uppdatering-under-covid-19-pandemin-684e713f 2020-05-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovias-uppdatering-nr-3-om-foretagets-svar-pa-covid-19-92a71732 2020-05-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-stammokommunike-e0bc5f31 2020-05-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-rapporterar-delarsrapport-for-forsta-kvartalet-januari-mars-2020-b5d15ba0 2020-04-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-mars-2020-den-28-april-2020-3af3b277 2020-04-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-och-globalt-lakemedelsbolag-overens-om-fortida-avslut-pa-lungcancersamarbete-b68977de 2020-04-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-af54fc92 2020-04-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-vidtar-atgarder-under-covid-19-pandemin-och-behaller-fokus-pa-lanseringen-av-immray-r-pancan-d-0113b96d 2020-04-01 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-en-uppdatering-om-bolagets-covid-19-status-13c378a0 2020-03-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelseledamot-hans-johansson-koper-immunovia-aktier-7d481fd0 2020-03-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publicerar-arsredovisningen-for-rakenskapsaret-2019-5dbcf7d2 2020-03-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bokslutskommunike-2019-fac1230e 2020-02-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-bokslutskommunike-for-2019-2220424e 2020-02-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kronprinsessan-och-prins-daniel-besokte-immunovia-i-lund-idag-46b23e86 2020-01-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-forstarker-management-med-ny-senior-vp-sales-north-america-infor-lanseringen-av-immray-r-pancan-d-c684738b 2020-01-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-uppnar-viktig-milstolpe-genom-framgangsrikt-slutforande-av-immray-r-pancan-d-commercial-test-model-study-med-hog-noggrannhet-a65d625f 2019-12-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-starker-ledningsteamet-infor-sin-kommersiella-lansering-av-immray-r-pancan-d-55a6c6d8 2019-12-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-fortsatter-med-nasta-fas-i-lungcancerprojektet-tillsammans-med-global-lakemedelspartner-08a56333 2019-11-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=korrigerad-version-immunovia-delarsrapport-januari-september-2019-58d959f7 2019-11-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-september-2019-8fa5ba04 2019-11-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-infor-arsstamma-2020-i-immunovia-ab-publ-ec1d6c15 2019-11-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-september-2019-den-8-november-2019-8ef5bff5 2019-10-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=uppdatering-fran-immunovia-om-dess-pipelineprojekt-inom-reumatoid-artrit-samt-meddelande-om-nytt-samarbete-75cee36f 2019-10-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lamnar-uppdatering-om-sina-pagaende-lungcancerprojekt-0164290c 2019-10-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-att-commercial-test-model-study-fortskrider-enligt-plan-6c1cd2e0 2019-09-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nytt-aktiekapital-och-antal-aktier-i-immunovia-888ebd9c 2019-09-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=vissa-personer-i-ledningsgruppen-har-salt-aktier-for-att-mojliggora-finansiering-av-aktier-via-immunovias-optionsprogram-4dfd309f 2019-09-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-och-universitetssjukhus-i-varldsklass-slutfor-avtal-om-insamling-av-blodprov-i-bukspottkortelcancer-for-immray-r-pancan-d-6c7d63be 2019-09-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillkannager-agendan-for-dagens-webinar-4d525018 2019-09-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-haller-en-webinarserie-om-immray-r-pancan-d-3c8607f9 2019-09-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-juni-2019-ce374562 2019-08-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-april-juni-2019-den-23-augusti-2019-dc9d644b 2019-08-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=erlangens-universitetssjukhus-och-immunovia-ingar-samarbetsavtal-om-insamling-av-blodprov-vid-bukspottkortelcancer-for-de-sista-stegen-i-immray-r-pancan-d-utvecklingen-bedc2a42 2019-07-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=resultat-fran-optimeringsstudien-immray-pancan-d-presenteras-pa-pancreasfest-2019-512e9851 2019-07-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-vd-mats-grahn-saljer-48-000-immunovia-aktier-till-en-svensk-institutionell-investerare-a6e81699 2019-06-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-utmarkta-resultat-for-samtliga-symptomatiska-riskgrupper-fran-optimeringsarbetet-med-immray-r-pancan-d-3a6b1544 2019-06-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-panfam-1-den-storsta-studien-for-arftlig-bukspottkortel-cancerrisk-tar-fart-i-usa-3b3f778d 2019-05-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-pa-jefferies-2019-global-healthcare-conference-i-new-york-city-4-7-juni-2019-019eaf48 2019-05-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-meddelar-att-optimeringsarbetet-fortskrider-i-tid-och-enligt-plan-4397e775 2019-04-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-stammokommunike-2fde206a 2019-04-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=korrigerad-version-immunovia-kvartalsrapport-januari-mars-2019-a389d23e 2019-04-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-kvartalsrapport-januari-mars-2019-7dcee63c 2019-04-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-okar-strategiskt-samarbete-med-primarvardslakare-i-usa-for-att-skapa-medvetenhet-om-betydelsen-av-tidigt-upptackt-av-bukspottkortelcancer-d4506d98 2019-04-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=korrigerad-version-immunovia-och-university-college-of-london-tecknar-avtal-om-att-utvidga-valideringsstudierna-av-immray-r-pancan-d-for-tidiga-tecken-och-symptom-bc434b15 2019-04-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-och-university-college-of-london-tecknar-avtal-om-att-utoka-valideringsstudierna-av-immray-r-pancan-d-for-tidiga-tecken-och-symptom-3366a12d 2019-04-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-112fe39c 2019-03-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-arsredovisning-for-rakenskapsaret-2018-575aed10 2019-03-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillhandahaller-uppdatering-av-optimeringsarbetet-for-att-uppna-forvantad-prestanda-for-kommersialisering-av-immray-r-pancan-d-dac97995 2019-03-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bokslutskommunike-januari-december-2018-d4dfc6da 2019-02-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-deltar-i-kommande-investerarkonferenser-i-mars-8a5d8293 2019-02-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-bokslutskommunike-for-2018-1c0d9daa 2019-02-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-utser-julie-silber-till-senior-director-of-investor-relations-edbf9afa 2019-02-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nya-europeiska-kliniker-till-immunovias-panfam-1-den-storsta-prospektiva-kliniska-multicenterstudien-nagonsin-for-tidig-upptackt-av-bukspottkortelcancer-f969b1a9 2019-02-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-bjudits-in-att-presentera-vid-jefferies-2018-london-healthcare-conference-264e62aa 2018-11-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=mcgill-yale-och-universiteten-i-pennsylvania-och-massachusetts-deltar-i-panfam-1-den-storsta-prospektiva-kliniska-multicenterstudien-nagonsin-for-tidig-upptackt-av-bukspottkortelcancer-59526224 2018-11-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-september-2018-1ff837aa 2018-11-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-sponsrar-symposium-inom-primarvardsutbildning-pa-fenway-park-tillagnat-world-pancreatic-cancer-day-117c7b70 2018-11-06 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-september-2018-den-7-november-2018-9302223f 2018-11-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-infor-arsstamma-2019-i-immunovia-ab-publ-6e28f952 2018-10-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-annonserar-strategiskt-fokus-pa-immray-r-blodbaserade-biomarkorssignaturer-for-reumatoid-artrit-inom-autoimmuna-sjukdomar-364cb0e7 2018-10-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-kliniska-studie-panfam-1-finns-nu-i-clinicaltrials-gov-varldens-storsta-databas-for-kliniska-studier-b8915097 2018-10-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-telefonkonferens-den-8-oktober-2018-angaende-immunovias-strategi-for-autoimmuna-sjukdomar-5644c0bf 2018-09-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nytt-aktiekapital-och-antal-aktier-i-immunovia-1624d07b 2018-09-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-juni-2018-12bd1dbc 2018-08-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-delarsrapport-januari-juni-2018-samt-kommentarer-kring-tidigare-publicerade-studieresultat-inom-autoimmunitet-829e1bf7 2018-08-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=genombrott-inom-autoimmun-testning-en-immray-baserad-biomarkorssignatur-identifierar-patienter-med-anti-ccp-negativ-reumatoid-artrit-1dacf31c 2018-08-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=resultat-fran-retrospektiv-studie-for-immray-r-pancan-d-visar-att-immunovia-behover-utfora-optimeringar-for-att-uppfylla-forvantad-prestanda-049405e4 2018-08-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=journal-of-clinical-oncology-publicerar-att-immray-r-pancan-d-serumbiomarkorstestet-upptacker-tidig-bukspottkortelcancer-med-96-noggrannhet-cac4c264 2018-08-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telekonferens-torsdagen-den-9-augusti-2018-kl-15-00-be309c80 2018-08-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-blodbaserade-immray-r-biomarkorsarray-ger-hog-noggrannhet-vid-diagnos-av-icke-smacellig-lungcancer-i-en-ny-samarbetsstudie-da1a72aa 2018-08-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=karolinska-institutet-deltar-i-immunovias-panfam-1-prospektiva-kliniska-studie-for-tidig-upptackt-av-bukspottkortelcancer-med-blodbaserat-test-ef878151 2018-08-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=forandring-av-antal-aktier-och-roster-i-immunovia-ab-publ-c03459e1 2018-06-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-genomfort-en-riktad-nyemission-om-cirka-324-miljoner-kronor-250fc6dd 2018-06-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-avsikt-att-genomfora-en-riktad-nyemission-e8789656 2018-06-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=universitetssjukhuset-i-linkoping-blir-den-andra-svenska-kliniken-i-den-storsta-prospektiva-kliniska-studien-av-tidig-upptackt-av-bukspottkortelcancer-2abf1d48 2018-05-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=ledande-spansk-klinik-deltar-i-rekordstor-studie-avseende-familjar-bukspottkortelcancer-31ae1efa 2018-05-04 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-stammokommunike-c3ef81df 2018-05-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-kvartalsrapport-januari-mars-2018-64398f29 2018-04-27 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-kvartalsrapport-januari-mars-2018-den-27-april-2018-9a5ac3c0 2018-04-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-kvartalsrapport-januari-mars-2018-den-27-april-2018-1e4ea94e 2018-04-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nyu-school-of-medicine-ansluter-sig-till-panfam-1-den-prospektiva-studien-for-tidig-upptackt-av-bukspottkortelcancer-hos-familjara-riskgrupper-3b99cf9e 2018-04-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-389404f0 2018-04-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-prospekt-i-samband-med-listbytet-till-nasdaq-stockholm-780f3731 2018-03-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-godkants-for-notering-pa-nasdaq-stockholm-e788dd94 2018-03-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lanserar-idag-en-ny-hemsida-c98e731f 2018-03-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-publishes-the-annual-report-for-the-financial-year-2017-bb4b5a29 2018-03-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-arsredovisning-for-rakenskapsaret-2017-5a89fd76 2018-03-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-finansiella-mal-ccf8118a 2018-03-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=den-spanska-kliniken-santiago-de-compostela-gar-med-i-den-storsta-prospektiva-studien-nagonsin-avseende-arftlig-risk-att-utveckla-bukspottkortelcancer-b0da2a04 2018-02-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bokslutskommunike-januari-december-2017-ef4dabfc 2018-02-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-immunovias-bokslutskommunike-2017-den-15-februari-2018-cb6bbf7d 2018-02-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=massachusetts-general-hospital-gar-med-i-den-prospektiva-studien-panfam-1-for-tidig-diagnos-av-bukspottkortelcancer-hos-kanda-hogriskgrupper-1fc1f6c3 2018-02-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-accelererar-bukspottkortelcancerstudie-av-diabetespatienter-genom-samarbete-med-dansk-center-for-strategisk-forskning-i-type2-diabetes-dd2-990317be 2018-01-11 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-expanderar-multicenterstudien-for-tidig-upptackt-av-cancer-i-bukspottkorteln-genom-samarbete-med-valrenommerade-university-of-pittsburgh-7e46f2d7 2017-12-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=sahlgrenska-ar-forsta-svenska-deltagaren-i-hittills-storsta-prospektiva-multicenterstudien-for-tidig-upptackt-av-cancer-i-bukspottkorteln-9a311c33 2017-12-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telekonferens-den-20-december-2017-pa-engelska-e21e8163 2017-12-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-paborjar-varldens-mest-omfattande-studie-av-diabetespatienter-i-en-prospektiv-bukspottkortelcancerstudie-stodd-av-swelife-8c8bf9e1 2017-12-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=h-m-konung-carl-xvi-gustaf-besokte-igar-immunovia-med-iva-kungliga-teknikresa-5eabbb51 2017-11-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=world-pancreatic-cancer-day-is-today-if-pancreatic-cancer-is-found-early-it-saves-lives-95f40ceb 2017-11-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-13-november-2017-90f55fd9 2017-11-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-september-2017-c83ec1e0 2017-11-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=valberedning-utsedd-infor-arsstamma-2018-i-immunovia-ab-publ-50b66f04 2017-11-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=university-college-london-hospital-paborjar-insamlingen-av-blodprov-for-att-utvardera-immunovias-immray-pancan-d-for-patienter-med-symptom-d762c2d8 2017-11-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nytt-aktiekapital-och-antal-aktier-i-immunovia-2693f3f4 2017-10-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tilldelas-4-9-msek-fran-swelifes-acceleratorutlysning-d3ce32ab 2017-10-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-storskaligt-samarbete-med-linkopings-universitet-kring-upptackten-av-autoimmuna-biomarkorer-ec6777e8 2017-10-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-haller-tidsplan-for-ansokan-om-notering-pa-nasdaq-stockholms-huvudlista-87d39561 2017-10-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=ledning-och-anstallda-i-immunovia-tecknar-nya-aktier-med-stod-av-teckningsoptioner-5d4c849d 2017-09-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-samarbete-med-lunds-universitets-diabetescentrum-i-arbetet-for-tidig-upptackt-av-pankreascancer-hos-diabetesriskgrupp-3c745e8a 2017-09-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-juni-2017-2da7307f 2017-08-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-23-augusti-2017-8ba6352f 2017-08-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=global-expert-pa-bukspottkortelcancer-professor-stephen-pereira-vid-university-college-london-utsedd-till-immunovias-scientific-advisory-board-03e25740 2017-07-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tilldelas-i-samarbete-med-oregon-health-and-science-university-ett-av-forskningsanslagen-fran-pancreatic-cancer-action-network-2017-9c217042 2017-06-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-etablerar-huvudkontor-for-usa-verksamheten-och-ackrediterat-referenslaboratorium-i-boston-d2a222ed 2017-06-28 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-immray-biomarkorer-sarskiljer-reumatoid-artrit-fran-andra-autoimmuna-sjukdomar-med-en-traffsakerhet-pa-89-772c763c 2017-06-21 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-offentliggor-tidplan-for-ansokan-om-notering-pa-nasdaq-stockholms-huvudlista-44080e2e 2017-06-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-biomarkor-signatur-for-diagnos-av-pankreascancer-nu-patenterad-i-japan-fba2bcae 2017-06-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-stammokommunike-5cc6f748 2017-04-25 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-delarsrapport-januari-mars-2017-c2613d7b 2017-04-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-20-april-2017-6e18cb70 2017-04-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-kallar-till-arsstamma-och-publicerar-arsredovisning-for-rakenskapsaret-2016-602a994c 2017-03-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=slutgiltiga-data-fran-omfattande-svensk-studie-bekraftar-att-immray-biomarkorer-sarskiljer-sle-fran-andra-autoimmuna-sjukdomar-med-96-traffsakerhet-9f08257b 2017-03-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-tillkannager-genomford-blocktransaktion-i-bolagets-aktier-ae3f3343 2017-02-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bokslutskommunike-2016-8e7781dd 2017-02-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-15-februari-2017-caabe1ff 2017-02-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-vid-vator-securities-unicorn-summit-c4b3e743 2017-02-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=university-of-michigan-pancreatic-cancer-center-ny-samarbetspartner-i-immunovias-globala-prospektiva-valideringsstudie-panfam-1-9def8c3c 2017-01-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-telefonkonferens-tisdag-17-1-kl-16-00-4db89e84 2017-01-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-forsta-data-pavisar-over-90-traffsakerhet-i-att-skilja-systemic-lupus-erythematosus-sle-fran-andra-autoimmuna-sjukdomar-i-ny-studie-1063f1a8 2017-01-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=nyhetsbrev-till-aktieagarna-i-immunovia-q4-2016-daed1492 2016-12-22 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-telefonkonferens-idag-20-12-kl-16-00-412f993f 2016-12-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-panfam-1-varldens-hittills-storsta-prospektiva-multicenterstudie-for-tidig-upptackt-av-cancer-i-bukspottskorteln-dc231cba 2016-12-20 https://investors.immunovia.com/pressmeddelanden/artikel?slug=paminnelse-immunovia-bjuder-in-till-telefonkonferens-idag-15-12-kl-16-00-4ceeca04 2016-12-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bjuder-in-till-telefonkonferens-torsdag-15-12-kl-16-00-3338b443 2016-12-12 https://investors.immunovia.com/pressmeddelanden/artikel?slug=stammokommunike-051feee2 2016-12-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-samarbete-med-nci-avseende-utveckling-och-validering-av-biomarkorer-for-cancer-i-bukspottskorteln-hos-riskgruppen-diabetespatienter-1151105b 2016-12-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-samarbete-med-det-valrenommerade-ramon-y-cajal-institute-for-health-research-irycis-i-madrid-8e92f028 2016-12-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-awarded-2016-stars-of-innovation-prize-98cbc466 2016-11-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-immunovia-ab-publ-e5a8b95e 2016-11-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=world-pancreatic-cancer-day-lund-sweden-november-17-2016-its-about-time-4cbc2b2a 2016-11-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-utfall-i-foretradesemissionen-om-28-7-miljoner-kronor-utover-den-tidigare-riktade-emissionen-om-189-9-miljoner-kronor-f7a3291e 2016-10-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-har-utsetts-till-ett-av-de-tre-mest-innovativa-bolagen-i-europa-2016-i-segmenten-small-till-mid-cap-2c09ac91 2016-10-13 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-insynspersoner-overlater-teckningsratter-vederlagsfritt-a9d508d9 2016-10-07 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-prospekt-avseende-foretradesemission-4615aadf 2016-09-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=styrelsen-i-immunovia-beslutar-om-riktad-emission-och-foretradesemission-9475de8d 2016-09-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-avser-att-genomfora-riktad-emission-och-foretradesemission-a024ecf8 2016-09-14 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-i-djupgaende-diskussioner-om-medverkan-i-stort-konsortium-gallande-storsta-riskgruppen-for-pankreascancer-nya-diabetiker-over-50-ar-bec57fe2 2016-09-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-halvarsrapport-2016-1e389127 2016-08-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-24-augusti-2016-6840e87e 2016-08-17 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-offentliggor-avsikt-att-ansoka-om-notering-pa-nasdaq-stockholms-huvudmarknad-fba2ff8b 2016-08-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=professor-diane-simeone-vid-universitetssjukhuset-i-michigan-ar-den-senaste-utnamningen-till-immunovias-vetenskapliga-advisory-board-e30de690 2016-07-15 https://investors.immunovia.com/pressmeddelanden/artikel?slug=varldsledande-expert-i-cancerdiagnostik-professor-aldo-scarpa-utsedd-till-immunovia-scientific-advisory-board-5330a624 2016-07-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=en-ledande-amerikansk-expert-pa-cancer-i-magtarmomradet-professor-margaret-tempero-ar-utsedd-till-immunovias-scientific-advisory-board-c879a43c 2016-06-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=stammokommunike-558652b4 2016-05-31 https://investors.immunovia.com/pressmeddelanden/artikel?slug=dubbelt-sa-hog-chans-att-overleva-pankreascancer-ar-2020-4591c62d 2016-05-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=96-av-alla-patienter-i-ett-tidigt-stadium-av-pankreascancer-upptacktes-i-en-klinisk-valideringsstudie-a9539b0a 2016-05-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=inbjudan-till-immunovia-informationsmote-i-stockholm-den-1-juni-kl-17-30-med-vd-mats-grahn-och-styrelseordforande-carl-borrebaeck-b3609d1c 2016-05-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ansluter-sig-till-fler-an-40-globala-organisationer-som-samarbetar-mot-bukspottskortelcancer-vid-invigningsmote-6944ef79 2016-05-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-kallar-till-arsstamma-2016-7f315b97 2016-04-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-utser-dr-marco-del-chiaro-fran-karolinska-institutet-till-scientific-advisory-board-36d12cf8 2016-04-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=note-about-immunovia-and-immray-technology-information-on-newswires-and-social-media-181fc49f 2016-04-01 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-samarbete-med-ledande-konsultforetag-d4cfb40b 2016-03-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-lanserar-hemsida-pa-svenska-e38efd1a 2016-03-08 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-samarbete-med-multinationellt-lifescience-foretag-om-nytt-diagnostiskt-test-inom-systemisk-lupus-erythematosus-sle-59e9a2f4 2016-02-29 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-bokslutskommunike-2015-5bf486f6 2016-02-24 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inbjuder-till-telefonkonferens-den-24-februari-2016-b0359a8a 2016-02-23 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-presenterar-vid-vator-securities-unicorn-summit-276e038b 2016-02-16 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-och-lunds-universitet-paborjar-valideringsstudier-avseende-test-for-diagnostisering-av-lupus-sle-71d64eb5 2016-02-10 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-inleder-samarbete-med-mount-sinai-health-system-for-validering-av-blodprovstest-for-tidig-upptackt-av-pankreascancer-f9fa26ac 2016-02-09 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-och-university-of-liverpool-inleder-samarbete-i-prospektiv-klinisk-studie-03e20f48 2016-01-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=ett-white-paper-beskriver-uppskattad-effekt-av-ny-biomarkordiagnostik-pa-overlevnad-vid-pankreascancer-dd539b07 2015-12-18 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immray-pancan-d-upptacker-98-procent-av-alla-fall-av-pankreascancer-i-en-retrospektiv-studie-av-1-400-blodprov-158b54a1 2015-12-03 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-aktie-steg-60-procent-forsta-handelsdagen-pa-nasdaq-first-north-och-omsatte-28-5-miljoner-kronor-91a1fbbb 2015-12-02 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-godkant-for-handel-pa-nasdaq-first-north-fran-1-december-2015-26e0cba2 2015-11-26 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovias-nyemission-overtecknad-fem-ganger-infor-notering-pa-nasdaq-first-north-f39f3155 2015-11-19 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-ab-offentliggor-prospekt-avseende-nyemission-av-aktier-infor-notering-pa-nasdaq-first-north-449c89f3 2015-10-30 https://investors.immunovia.com/pressmeddelanden/artikel?slug=immunovia-och-knight-cancer-institute-gor-gemensam-satsning-for-tidig-upptackt-av-pankreascancer-3db18919 2015-10-05 https://investors.immunovia.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-immunovia-ab-62b5e44e 2015-09-30